Gambaran Terapi dan Luaran Infeksi Saluran Kemih oleh Bakteri Penghasil Extended Spectrum Beta Lactamase pada Anak di RSUD Dr. Soetomo Surabaya

Ahmad Muhajir, Priyo Budi Purwono, Samsriyaningsih Handayani

Sari


Latar belakang. Kasus infeksi saluran kemih oleh bakteri penghasil extended spectrum beta-lactamase (ESBL) dilaporkan sudah banyak terjadi di dunia. Informasi terkait ESBL di Indonesia sangat sedikit, terutama pada pasien anak.
Tujuan. Mengkaji gambaran terapi serta luaran pasien infeksi ESBL di RSUD Dr. Soetomo Surabaya periode Januari-Juni 2014.
Metode. Penelitian observasional dengan studi deskriptif, digunakan data rekam medis pasien anak RSUD Dr. Soetomo Surabaya periode Januari-Juni 2014. Variabel penelitian meliputi bakteri, uji sensitivitas, terapi serta status luaran pasien.
Hasil. Pasien anak berjumlah 56, terbanyak penyebab ISK Klebsiella pneumoniae (60,7%). Uji sensitivitas tertinggi meropenem (90,5%). Pilihan terapi definitif meropenem (25%), status luaran membaik 78,57%.
Kesimpulan. Meropenem merupakan pilihan terapi infeksi ESBL pada pasien dengan keadaan klinis membaik. Kontrol penggunaan antibiotik secara rasional dibutuhkan untuk pencegahan infeksi ESBL


Kata Kunci


extended spectrum beta-lactamase; ESBL pada anak, pola sensitivitas antibiotik; resistensi antibiotik; infeksi saluran kemih

Teks Lengkap:

PDF

Referensi


Zorc JJ, Kiddoo DA, Shaw KN. Diagnosis and management of pediatric urinary tract infections. Clin Microbiol Rev 2005;18:417-22.

Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983;11:315-7.

Bauernfeind A, Hörl G. Novel R-factor borne betalactamase of Escherichia coli confering resistance to cephalosporins. Infection 1987;15:257-9.

World Healht Organization. Workshop on the containment of antimicrobial resistance in Europe. Wernigerode, Germany 26-27 February. WHO; 2004.

Sharma J, Meera S, Palap R. 2009. Detection of TEM and SHV in Escherichia Coli and Klabisella Pneumonia isolates in a tertiary care hospital from India. Indian J Med Res 2009;132:332-6.

Katzung, B. G. Farmakologi dasar dan klinik. Edisi ke-10. Jakarta: EGC; 2002.

Paterson DL, Bonomo RA. Extended-Spectrum β-lactamases:

A clinical update. Clin Microbiol Rev 2005;18:657-86.

Kuntaman, Santoso S, Wahjono H, Mertiniangsih NM, Lestari ES, Farida H, dkk. The sensitivity pattern of extended spectrum beta-lactamases producing bacteria against six antibiotic that routinely used in clinical setting. J Indon Med Assoc 2011;61:482-6.

Deana M, Gusman V, Mihajlović-ukropina M, Jelesić Z, Milosavljević B. Bloodstream infections in children caused by extended spectrum beta-lactamaseproducing Klebsiella pneumoniae. Arch Biol Sci Belgrade

;64:1339-47.

CLSI. Performance standards for antimicrobial susceptibility testing; eighteenth informational supplement. M100-S18, Vol.28 No.1, Replaces

M-100-S17, Vol.27 No.1. [serial online]; 2011. Diakses 14 Januari 2016. Didapat dari: www.CLSI.org

Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, dkk. Epidemiology of ciprofloxacin resistance and its relationship to extendedspectrum beta-lactamase production in Klebsiella

pneumoniae isolates causing bacteremia. Clin Infect Dis 2000;30:473-8.

European Committee on Antimicrobial Susceptibility Testing (EUCAST). Update of ESBL interpretation. European society of clinical microbiology and infectious disease. Diakses 14 Januari 2016. Didapat dari: www. eucast.org.

Rupp, Mark, Paul. Extended spectrum β-lactamase (ESBL)-producing Enterobacteriaceae considerations for diagnosis, prevention and drug treatment. USA: Department of Internal Medicine, University of Nebraska Medical Center. Drugs 2003; 63:353-65.

Trivedi M, Patel V, Soman R, Rodriguez C, Singhal T. The outcome of treating ESBL infections with carbapenems vs. non carbapenem antimicrobials. Assoc Physic India J 2012;60:28-30.

Lee B, Kang SY, Kang H, Yang N, Kang HG, Cheong H, dkk. Outcome of Antimicrobial therapy of pediatric urinary tract infections caused by extended-spectrum β-lactamase-producing Enterobacteriaceae. Korean Soc Infect Dis 2013;45:415-21.

Paterson DL, Mulazimoglu L, Casellas JM, Ko WC, Goossens H, Von Gottberg A, dkk. Epidemiology of ciprofloxacin resistance and its relationship to extendedspectrum beta-lactamase production in Klebsiella

pneumoniae isolates causing bacteremia.Clin Infect Dis 2000;30:473-8 .

Lukman ZA, Pemilihan antibiotik yang rasional. Medical Review 2014;27:40-5.




DOI: http://dx.doi.org/10.14238/sp18.2.2016.111-6

Refbacks

  • Saat ini tidak ada refbacks.


##submission.copyrightStatement##

##submission.license.cc.by-nc-sa4.footer##

Informasi Editorial:
Badan Penerbit Ikatan Dokter Anak Indonesia
Jl. Salemba I No 5, Jakarta 10430, Indonesia
Phone/Fax: +62-21-3912577
Email: editorial [at] saripediatri.org

Lisensi Creative Commons
Sari Pediatri diterbitkan oleh Badan Penerbit Ikatan Dokter Anak Indonesia
Ciptaan disebarluaskan di bawah Lisensi Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.